Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07705373 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson Disease

Study acronym: MyMusiQ
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study description shortened, about 214 wordsv5
  2. Start date changed from estimate of Aug 2026 to Aug 20, 2026v4
  3. Interventions: Digital Music Device (MedRhythms, Inc., Portland, ME) (Device) to MR-005 (MedRhythms, Inc., Portland, ME) (Device)
    • Eligibility criteria revised
    v3
  4. Recruitment opened
    • Start date: Jul 2026 to Aug 2026
    • Site details revised at 3 of 3 sites
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this research study is to examine the effects of a 3-month personalized community-based walking program using a digital music-based device designed for self-directed gait training in people with Parkinson disease (PD). The study uses music cues delivered through this digital device to improve walking outcomes. The investigators want to know if personalized music cueing through the digital device can improve walking quality, walking ability, daily walking amount and intensity, and quality of life, while helping walking feel more automatic and require less mental effort. Participants will take part in this research study for approximately 18 weeks in total. During this time, participants will complete 4 study visits at designated research centers at Boston University, Washington University in St. Louis, or the University of Utah, depending on the site of enrollment.
Trial Details
NCT Number NCT07705373
Lead Sponsor Boston University Charles River Campus
Collaborators: Michael J. Fox Foundation for Parkinson's Research, University of Utah, Washington University School of Medicine
Conditions
(from sponsor)		 Parkinson's Disease (PD)
Related terms Parkinson Disease
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov